Beyond immuno-oncology, AstraZeneca builds up 'DNA damage' drugs Drugs targeting DNA repair mechanisms inside cells are showing real promise for a range of tumors and AstraZeneca believes it is well ahead of rivals in the emerging cancer field.
Mom killed disabled daughter so she'd be 'in heaven with me' An Illinois woman accused of giving her severely disabled adult daughter a fatal dose of meds last year before trying to kill herself stood before a Cook County judge Wednesday, explaining that her love for her daughter was so strong that killing her seemed the most humane thing to do.
FDA fast-tracks treatment that uses polio virus to fight brain cancer The Food and Drug Administration has approved a new therapy that uses the once-feared polio virus to target aggressive forms of brain cancer.
How much palliative care breast cancer patients get may depend on race When women have advanced breast cancer, the amount of comfort-oriented care they receive at the end of life may depend on the color of their skin, a small U.S. study suggests.
Car door windows don't stop UV rays Car windows don't protect against harmful sun exposure, so it might be a good idea to wear sunglasses and sun block even while driving, a new study suggests.
Eating fruit in early life may decrease breast cancer risk; drinking more in midlife may increase risk Consuming certain fruits and vegetables during adolescence may result in a reduced risk of breast cancer in midlife, while increasing alcohol intake later in life may increase that risk, two separate studies released this week suggest.
AstraZeneca drug wins orphan status in thyroid cancer An experimental AstraZeneca drug that failed last year as a treatment for a rare cancer of the eye has been awarded special "orphan" status in the United States for a type of thyroid cancer.
